Author:
Tesso Zerubabel Girma,Gossaye Tariku Yigremachew,Bekana Dereje Sileshi,Kebede Molla Asnake,Besir Fikretsion Degemu,Dabe Nikodimos Eshetu
Abstract
Abstract
Background
Neonatal malaria is defined as the detection of asexual stages of Plasmodium species in the cord blood within the first 28 days of life. It can be congenital or acquired through mosquito bites or blood transfusions. Neonates are generally considered to be relatively protected due to the multiple innate and acquired physiological protective effects present in neonates. However, in areas where malaria is endemic, the prevalence of malaria in neonates is high. The predominant clinical feature of malaria in neonates is fever. Other clinical manifestations of neonatal malaria include respiratory distress, pallor and anaemia, hepatomegaly, refusal to feed, jaundice and diarrhoea. Atypical presentations without fever can lead to inaccurate diagnosis and contribute to neonatal morbidity and mortality. Neonates from endemic areas with any of the above symptoms should be screened for malaria.
Case presentation
We present a series of three cases of neonatal Plasmodium falciparum malaria that presented atypically without febrile episodes and were diagnosed and managed at Mizan-Tepi University Teaching Hospital between July and September 2023. The first patient presented with vomiting, refusal to feed, pallor, severe anaemia, and splenomegaly. The second patient presented with an inconsolable cry, failure to pass feces, abdominal distention, and anaemia. The third patient presented with vomiting and anaemia. All patients received a 7-day course of intravenous artesunate; the first patient also received a blood transfusion. All patients recovered and were discharged.
Conclusions
Partial immunity resulting from repeated malaria infections in endemic regions may result in the transfer of high levels of maternal Immunoglobulin G (IgG) antibodies through the placenta and can produce different atypical clinical presentations. In malaria-endemic areas, neonates presenting with any of the presenting signs and symptoms of malaria, including afebrile presentation, require malaria screening to avoid delays in diagnosis.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Rodriguez JA, Roa AA, Leonso-Bravo AA, Khatiwada P, Eckardt P, Lemos-Ramirez J. A case of Plasmodium falciparum malaria treated with artesunate in a 55-year-old woman on return to Florida from a visit to Ghana. Am J Case Rep. 2020;21: e926097.
2. WHO. World malaria report 2023. Geneva: World Health Organization; 2023.
3. WHO. Child mortality (under 5 years). Geneva: World Health Organization. 2022. https://www.who.int/news-room/fact-sheets/detail/levels-and-trends-in-child-under-5-mortality-in-2020. Accessed 28 Oct 2023.
4. Biset G, Tadess AW, Tegegne KD, Tilahun L, Atnafu N. Malaria among under-five children in Ethiopia: a systematic review and meta-analysis. Malar J. 2022;21:338.
5. Esayas E, Tufa A, Massebo F, Ahemed A, Ibrahim I, Dillu D, et al. Malaria epidemiology and stratification of incidence in the malaria elimination setting in Harari Region, Eastern Ethiopia. Infect Dis Poverty. 2020;9:160.